Filing Details

Accession Number:
0001104659-24-108375
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-15 08:31:01
Reporting Period:
2024-10-10
Accepted Time:
2024-10-15 08:31:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1781983 Aprea Therapeutics Inc. APRE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1929300 Oren Gilad 3805 Old Easton Road
Doylestown PA 18902
President/Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-10-10 150 $2.54 331,645 No 4 P Direct
Common Stock Acquisiton 2024-10-14 1,000 $2.59 332,645 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,200 Indirect By Daughter
Common Stock 600 Indirect By Son
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.